Journal profile · UROLOGY & NEPHROLOGY

BMC Urology

ISSN 1471-2490 · BioMed Central · ENGLAND · Founded 2001

BMC Urology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.33; fully open access; APC about USD 3,090; median 134 days to acceptance (121 articles, last 24 months); community-reported acceptance: fairly easy; 338 articles in 2025; indexed in SCIE and Scopus.

Impact factor2.33Latest value listed by LetPub
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time134 daysMedian, submission to acceptance · 121 articles, last 24 months · Crossref
APCUSD 3,090Fully open access
AcceptanceFairly easyCommunity average
Articles per year3382025 · OpenAlex count

Scope

Aims, scope and focus

BMC Urology is published by BioMed Central and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Bladder and Urothelial Cancer Treatments, Kidney Stones and Urolithiasis Treatments and Prostate Cancer Diagnosis and Treatment, together about 28.5% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)

BMC Urology is an open access journal publishing original peer-reviewed research articles in all aspects of the prevention, diagnosis and management of urological disorders, as well as related molecular genetics, pathophysiology, and epidemiology. The journal welcomes manuscripts in the following broad areas of urology research: Andrology, Sexual Function And Fertility – focuses on male and female sexual and reproductive health, encompassing male reproductive health and related disorders such as infertility, erectile dysfunction, testicular function issues, hypogonadism, hormonal therapy, and prostatic diseases with reproductive implications, as well as broader perspectives including sexual dysfunction in men and women (e.g., erectile dysfunction, premature ejaculation, female sexual dysfunction and genital pain disorders), infertility diagnostics and treatments (e.g., azoospermia, varicocele), fertility preservation strategies, hormonal modulation therapies, the effects of urological conditions on sexual wellbeing, and the psychosexual and quality-of-life impacts of urological treatments. Endourology and New Technology – highlights technological innovation and minimally invasive techniques like robotic and laparoscopic procedures, novel surgical tools or platforms, laser therapies (e.g., for BPH or stones), stent designs and urinary drainage innovations, AI and digital tools for procedural optimization, development of surgical instruments and stents, telemedicine tools and surgical training platforms and integration of AI, imaging guidance, and augmented reality Epidemiology and Health Outcomes – explores population-level insights and health system impacts like prevalence, risk factor, and burden studies, health economics and cost-effectiveness, patient-reported outcome measures (PROMs), longitudinal cohort analyses, screening program evaluations, real-world effectiveness of treatments, healthcare access and disparities, and health economics and cost-effectiveness of interventions Female Urology, Neurourology and Voiding Dysfunction – centers on functional disorders and neurological control of urination including urinary incontinence and retention, overactive bladder and interstitial cystitis, pelvic organ prolapse, overactive bladder and urgency incontinence, neurogenic bladder and spinal cord injury sequelae, nocturia, retention, and obstructive voiding, pelvic floor dysfunction and urodynamic testing, and behavioral and surgical interventions. Pediatri

From the journal's Aims & Scope

Research area (LetPub): UROLOGY & NEPHROLOGY

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Bladder and Urothelial Cancer TreatmentsMedicine9.8%
  2. Kidney Stones and Urolithiasis TreatmentsMedicine9.4%
  3. Prostate Cancer Diagnosis and TreatmentMedicine9.3%
  4. Urinary Bladder and Prostate ResearchMedicine9.3%
  5. Ureteral procedures and complicationsMedicine7.2%
  6. Pelvic floor disorders treatmentsMedicine6.2%
  7. Urinary Tract Infections ManagementMedicine6%
  8. Prostate Cancer Treatment and ResearchMedicine5.4%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorUrology & NephrologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorUrology & NephrologyZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorUrology & NephrologyZone 4

Top journal: noReview journal: no

Database indexing

SCIEScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

MEDLINEEmbaseCASPublisher website

Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
2.33LetPub ·
Impact factor (publisher) 2025
2.3Publisher website ·
5-year impact factor (publisher) 2025
2.3Publisher website ·
CiteScore 2026-06
3.1LetPub ·
SJR 2026-06
0.66LetPub ·
SNIP 2026-06
1.02LetPub ·
h-index
35LetPub ·
h-index
71OpenAlex ·
i10-index
1,093OpenAlex ·
2-year mean citedness
2.4OpenAlex ·
Self-citation rate
0%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
331LetPub ·
Downloads per year (publisher) 2025
2,000,000Publisher website ·

Articles by year OpenAlex count · 2,742 in total · the current year is incomplete

YearArticlesOpen accessCitations
202632932946
2025338338776
20242892891,470
20232122121,451
20222142141,972
20211851852,215

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

134 daysMedian, submission to acceptance · P25–P75 83 days – 190 days

Acceptance to online
median 11 days (121 articles)
Submission to online
median 153 days
Sample
121 articles with submission and acceptance dates (738 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
over 12 weeksLetPub ·
Average acceptance (community reports)
Fairly easyLetPub ·
Submission to first decision
18 daysPublisher website ·
Submission to publication (journal-reported)
about 21 weeksDOAJ ·
Peer review
Open peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJEUR 2,690 / USD 3,090 / GBP 2,390YesCC BY, CC BY-NC-ND
OpenAlexUSD 2,990 / EUR 2,590 / GBP 2,290——
LetPubGBP 2,090 / USD 2,790 / EUR 2,390Yes—
Publisher websiteGBP 2,390 / USD 3,090 / EUR 2,690——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Open calls for papers3, by deadline
  1. Advances in focal therapy for prostate cancerDeadline
  2. Recent advances, opinions and management of hypospadias - Part IIDeadline
  3. Bladder cancerDeadline
Publisher website
What to prepare2 items from the author guidelines
Suggested reviewers
Optional
Cover letter
Required
Publisher website · model-extracted, each line checked against the text
Article types accepted7
  1. case reportResearch article Case report Study protocol Review Matters Arising Comment Systematic ReviewLength not stated
  2. commentResearch article Case report Study protocol Review Matters Arising Comment Systematic ReviewLength not stated
  3. matters arisingResearch article Case report Study protocol Review Matters Arising Comment Systematic ReviewLength not stated
  4. research articleResearch article Case report Study protocol Review Matters Arising Comment Systematic ReviewLength not stated
  5. reviewResearch article Case report Study protocol Review Matters Arising Comment Systematic ReviewLength not stated
  6. study protocolResearch article Case report Study protocol Review Matters Arising Comment Systematic ReviewLength not stated
  7. systematic reviewResearch article Case report Study protocol Review Matters Arising Comment Systematic ReviewLength not stated
Publisher website
Policy excerpts from the journal's websiteData availability, License & copyright, Open access, Peer review
Data availability Formatting the 'Availability of data and materials' section of your manuscript

The following format for the 'Availability of data and materials section of your manuscript should be used:

Source ↗Publisher website ·
License & copyright Licensing and copyright

Open access under CC BY-NC-ND or CC BY licence. Model summary

Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. BMC Urology articles are published open access under a CC BY-NC-ND (Creative Commons Attribution Non-Commerc…

Source ↗Publisher website ·
Open access Benefits of open access

Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…

Source ↗Publisher website ·
Peer review Peer review policy

Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
BioMed Central
Country or region
ENGLAND
Language
English
Founded
2001
ISSN
1471-2490
Official links

FAQ

Frequently asked questions about BMC Urology

What CAS zone is BMC Urology in?

In the 2025 upgraded edition of the CAS Journal Ranking, BMC Urology is in Zone 4 of Medicine, and in Zone 4 of the minor category Urology & Nephrology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of BMC Urology?

The latest impact factor listed by LetPub is 2.33; CiteScore 3.1, h-index 71.

How long does peer review take at BMC Urology?

Based on the dates recorded on 121 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 134 days (interquartile range 83–190 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of BMC Urology?

According to the journal's author guidelines: Suggested reviewers: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Which databases index BMC Urology?

According to LetPub and DOAJ records, BMC Urology is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.

Is BMC Urology open access, and what is the APC?

BMC Urology is a fully open-access journal. APC about USD 3,090.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .